Preoperative Lymphangial Chemotherapy on Breast Carcinoma

LI Yisheng,WANG ShuKui,LV Jin,WANG Heming,HUANG Shuiqing,JI Lv
DOI: https://doi.org/10.3969/j.issn.1673-9701.2011.30.013
2011-01-01
Abstract:Objective To study the direct action of the lymphangial chemotherapy on lymph transferred cancer of the breast cancer.Methods Sixty patients with breast cancer,confirmed by preoperative puncture biopsy,were ramdomized into two groups.Group of LC: To inject the epirubicin absorbed by active carbon through the tissue around primary tumor 24 h before modified radical resection;group of VC:inject the aqueous solution of the epirubicin through the intravenous.Then we examined the cancerous tissue by means of the flow cytometry and examined the concentration of epirubicin in nodes by Zeeman atomic absorption spectrometry.The relapse and metastatic rate and survival rate in 3 or 5 years were compared.Results There was a marked difference between the LC and VC in the concentration of epirubicin,the SPF,rate of APO,the expression of Bcl-2.There was significant difference in relapse and metastatic rate and survival rate between the two groups.Conclusion The LC can promote the apoptosis of the transferred cancer in the lymph system and improve the concentration of epirubicin in nodes and improve the survival rate.
What problem does this paper attempt to address?